Marksans Pharma
MARKSANS.NS
$2.01
Share price
-1.06%
Change (1 day)
105.10%
Change (1 year)
Categories
Operating Margin for Marksans Pharma (MARKSANS.NS)
Operating Margin as of April 2024 (TTM): 16.61%
According to Marksans Pharma 's latest financial reports and stock price the company's current Operating Margin is 16.61%. At the end of 2022 the company had an Operating Margin of 16.72%.
Operating Margin history for Marksans Pharma from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 16.72% | -24.27% |
| 2021 | 22.08% | 58.67% |
| 2020 | 13.92% | 31.74% |
| 2019 | 10.56% | 93.62% |
| 2018 | 5.46% | 169.54% |
| 2017 | 2.02% | -83.08% |
| 2016 | 11.96% | -38.87% |
| 2015 | 19.57% | 42.65% |
| 2014 | 13.72% | 38.09% |
| 2013 | 9.93% | -120.18% |
| 2012 | -49.22% | -30.25% |
| 2011 | -70.56% | 2648.39% |
| 2010 | -2.57% | 32.1% |
| 2009 | -1.94% | -125.01% |
| 2008 | 7.77% | 101.61% |
| 2007 | 3.85% | -63.49% |
| 2006 | 10.56% | 6.53% |
| 2005 | 9.91% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.